ALGAE.PA Fermentalg SA
- Market cap
- EUR 45.5M
- P/E
- -
- P/B
- 1.43x
- ROE
- -52.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is ALGAE.PA undervalued?
Graham numberThe Graham number of Fermentalg SA cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Fermentalg SA fundamental analysis
No fundamental analysis for Fermentalg SA yet.
Fermentalg SA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Fermentalg SA
Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 20…
Full company profileFermentalg SA financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Fermentalg SA annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 705K | 1.27M | 2.31M | 1.89M | 2.21M | 5.65M | 7.65M | 4.06M | 11.5M | 13.4M | 29.7M |
| Gross Profit | 572K | 158K | 890K | -4.79M | -1.25M | -675K | -828K | 536K | 2.50M | 2.29M | -316K |
| Operating Income | -6.11M | -7.27M | -7.12M | -10.7M | -10.4M | -9.63M | -10.3M | -11.1M | -9.25M | -9.38M | -20.4M |
| EBITDA | -6.34M | -5.29M | -5.61M | -12.1M | -6.16M | -8.91M | -7.19M | -10.5M | -9.99M | -6.32M | -13.2M |
| Net Income | -7.56M | -7.27M | -8.09M | -17.3M | -6.88M | -6.85M | -9.87M | -14.1M | -12.9M | -9.44M | -16.8M |
| EPS | -0.63 | -0.56 | -0.47 | -0.97 | -0.32 | -0.19 | -0.24 | -0.32 | -0.17 | -0.09 | -0.16 |
| Balance Sheet | |||||||||||
| Total Assets | 46.1M | 54.0M | 46.7M | 34.5M | 41.9M | 60.9M | 57.5M | 50.2M | 51.1M | 36.4M | 43.3M |
| Total Liabilities | 9.51M | 12.8M | 12.4M | 16.0M | 21.6M | 13.9M | 15.6M | 19.4M | 18.4M | 11.3M | 11.4M |
| Shareholders' Equity | 36.6M | 41.2M | 34.3M | 18.6M | 20.3M | 47.0M | 42.0M | 30.8M | 32.8M | 25.2M | 31.9M |
| Cash & Short-term Investments | 15.7M | 21.8M | 12.5M | 8.02M | 11.8M | 26.0M | 15.9M | 11.2M | 20.6M | 6.62M | 10.8M |
| Total Debt | 3.35M | 7.96M | 8.36M | 11.6M | 15.8M | 9.61M | 11.0M | 15.4M | 12.6M | 5.02M | 3.93M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -3.47M | -7.16M | -4.11M | -7.03M | -8.57M | -7.66M | -8.24M | -8.69M | -531K | -6.60M | -20.0M |
| Capital Expenditure | 6.85M | 1.09M | 842K | 3.28M | 3.12M | 4.89M | 5.48M | 2.49M | 1.47M | 1.54M | 2.55M |
| Free Cash Flow | -10.3M | -8.26M | -4.95M | -10.3M | -11.7M | -12.5M | -13.7M | -11.2M | -2.00M | -8.13M | -22.6M |
| Ratios | |||||||||||
| ROE | -20.6% | -17.6% | -23.6% | -93.1% | -33.9% | -14.6% | -23.5% | -45.9% | -39.3% | -37.5% | -52.6% |
| ROA | -16.4% | -13.5% | -17.3% | -50.1% | -16.4% | -11.3% | -17.2% | -28.2% | -25.2% | -25.9% | -38.8% |
| Net Profit Margin | -1,072.2% | -571.0% | -350.4% | -916.0% | -311.9% | -121.3% | -129.1% | -348.6% | -112.0% | -70.5% | -56.6% |
| Debt to Equity | 0.09x | 0.19x | 0.24x | 0.62x | 0.78x | 0.20x | 0.26x | 0.50x | 0.38x | 0.20x | 0.12x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Fermentalg SA dividends
Fermentalg SA has not paid dividends in the last 9 fiscal years.
Who owns Fermentalg SA
- Insiders 15.63%
- Institutions 17.92%
- Public & others 66.45%
- Shares outstanding 120M
- Free float 67.1M
Fermentalg SA company profile
- Company name
- Fermentalg SA
- Ticker
- ALGAE.PA
- ISIN
- FR0011271600
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 62
- Fiscal year end
- December
- Address
- 4 rue RiviA re, Libourne, France, 33500
- Phone
- 33 5 57 25 02 20
- Website
- fermentalg.com
About Fermentalg SA
Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw materials for industry from their CO2 emissions. The company was incorporated in 2009 and is headquartered in Libourne, France.
Fermentalg SA management
7- Mr. Pierre JosselinCEO & Director
- Matthieu De BlicFinancial Director
- Nicolas MalvertChief Operating Officer
- Dr. Hywel Griffiths Ph.D.Chief Scientific Officer
- Ms. Marie Jane FallourdMarketing & Products Director
- Mr. Nico BonneSales Director
- Ms. Emmanuelle Benitez CanoHuman Resources Director